| Percutaneous coronary intervention vs. medical therapy: what are the implications for women? | |
| | |
MedLine Citation:
|
PMID: 12150497 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
There have been eight major studies assessing percutaneous coronary intervention (PCI) vs. medical therapy in the past 10 years. Women were inadequately represented in many of these studies, but because of similar long-term survival curves in women and men, most of the PCI data can be applied to women until more trials are published. According to currently available data, PCI offers greater angina relief and improvement in exercise tolerance than medicine alone, but has a greater risk of procedure-related complications in women. As a result of the rapid advancement of cardiovascular therapy, many of these studies did not incorporate optimal medical therapy or current PCI therapies. It is likely that for most patients (including women) with moderate angina, the best management may be a combination of PCI, medical therapy, and lifestyle changes. |
| | |
Authors:
|
Megan Rist Haymart; Timm Dickfeld; Caitlin Nass; Roger S Blumenthal |
Related Documents
:
|
18753737 - Testosterone is a strong correlate of ghrelin levels in men and postmenopausal women. 15283937 - Does hormone therapy increase allergic reactions and upper gastrointestinal problems? r... 21992987 - Circumcision and acquisition of human papillomavirus infection in young men. 8515717 - The prevalence of oestrogen replacement therapy in south australia. 22692947 - Infertility insurance mandates and multiple births. 20429087 - Prevalence and risks for bacterial vaginosis in women who have sex with women. |
Publication Detail:
|
Type: Comparative Study; Journal Article; Review |
Journal Detail:
|
Title: Journal of women's health & gender-based medicine Volume: 11 ISSN: 1524-6094 ISO Abbreviation: J Womens Health Gend Based Med Publication Date: 2002 May |
Date Detail:
|
Created Date: 2002-08-01 Completed Date: 2002-11-21 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 100888719 Medline TA: J Womens Health Gend Based Med Country: United States |
Other Details:
|
Languages: eng Pagination: 347-55 Citation Subset: IM |
Affiliation:
|
The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Department of Internal Medicine, The Johns Hopkins Hospital, Baltimore, Maryland 21287, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Transluminal, Percutaneous Coronary* Anti-Arrhythmia Agents / therapeutic use Anticoagulants / therapeutic use Calcium Channel Blockers / therapeutic use Cardiac Surgical Procedures Coronary Artery Disease / mortality, therapy* Female Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use Male Randomized Controlled Trials as Topic Sex Factors Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Arrhythmia Agents; 0/Anticoagulants; 0/Calcium Channel Blockers; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from t...
Next Document: The enhancement of vaginal vasocongestion by sildenafil in healthy premenopausal women.